Positions

Overview

  • S. Vamsee Raju, B.Pharm, PhD. is an Assistant Professor in the School of Medicine, University of Alabama at Birmingham. He received his Pharmacy degree from Rajiv Gandhi University of Health Sciences in 2005. In 2011, he graduated with a PhD in Genetics from Louisiana State University Health Sciences Center in New Orleans.

    His graduate research identified two entirely new mechanisms by which alcohol affects innate airway defenses to cause lung infections. Dr. Raju then went on to complete a 2-year postdoctoral training in the laboratory of Steven Rowe investigating acquired CFTR dysfunction in COPD pathogenesis, followed by an Instructor faculty position in the Department of Medicine in 2013. His work is published in several prestigious journals and has received recognition through awards from the European Respiratory Society, the American Thoracic Society and the American Federation of Medical Research.

    • Selected Publications

    Academic Article

    Year Title Altmetric
    2019 Vaporized E-Cigarette Liquids Induce Ion Transport Dysfunction in Airway Epithelia 2019
    2019 Summary of the 2018 Alcohol and Immunology Research Interest Group (AIRIG) meeting 2019
    2019 Lessons Learned From Web- and Social Media-Based Educational Initiatives by Pulmonary, Critical Care, and Sleep Societies 2019
    2019 A Neutralizing Aptamer to TGFBR2 and miR-145 Antagonism Rescue Cigarette Smoke- and TGF-β-Mediated CFTR Expression 2019
    2019 Acquired cystic fibrosis transmembrane conductance regulator dysfunction and radiographic bronchiectasis in current and former smokers: A cross-sectional study 2019
    2018 Heme scavenging reduces pulmonary endoplasmic reticulum stress, fibrosis, and emphysema 2018
    2018 Maternal smoking induces acquired CFTR dysfunction in neonatal rats 2018
    2018 Not simply the lesser of two evils 2018
    2017 Use of ferrets for electrophysiologic monitoring of ion transport 2017
    2017 Roflumilast reverses CFTR-mediated ion transport dysfunction in cigarette smoke-exposed mice 2017
    2017 The cystic fibrosis transmembrane conductance regulator potentiator ivacaftor augments mucociliary clearance abrogating cystic fibrosis transmembrane conductance regulator inhibition by cigarette smoke 2017
    2016 A ferret model of COPD-related chronic bronchitis 2016
    2016 Pilot evaluation of ivacaftor for chronic bronchitis 2016
    2016 Therapeutic approaches to acquired cystic fibrosis transmembrane conductance regulator dysfunction in Chronic bronchitis 2016
    2016 Acquired Cystic Fibrosis Transmembrane Conductance Regulator Dysfunction in Chronic Bronchitis and Other Diseases of Mucus Clearance 2016
    2015 Recovery of acquired cystic fibrosis transmembrane conductance regulator dysfunction after smoking cessation 2015
    2014 Impact of heterozygote CFTR Mutations in COPD patients with Chronic Bronchitis 2014
    2014 Cystic fibrosis transmembrane conductance regulator activation by roflumilast contributes to therapeutic benefit in chronic bronchitis 2014
    2013 Cigarette smoke induces systemic defects in cystic fibrosis transmembrane conductance regulator function 2013
    2013 Cigarette smoke and CFTR: Implications in the pathogenesis of COPD 2013
    2013 Acquired cystic fibrosis transmembrane conductance regulator dysfunction in the lower airways in COPD 2013
    2012 A pharmacologic approach to acquired cystic fibrosis transmembrane conductance regulator dysfunction in smoking related lung disease 2012
    2012 Suppression of adenosine-activated chloride transport by ethanol in airway epithelia 2012
    2012 CFTR potentiator treatment of cystic fibrosis 2012
    2010 Ethanol upregulates glucocorticoid-induced leucine zipper expression and modulates cellular inflammatory responses in lung epithelial cells 2010

    Research Overview

  • Ongoing research in the laboratory is focused on pathophysiologic mechanisms of altered epithelial ion transport and its implications on mucociliary clearance and mucosal immunity in COPD and alcoholic pneumonia. Current research is supported by institutional funds and extramural grants from American Lung Association, Flight Attendants Medical Research Institute, National Institutes of Health and the pharmaceutical industry.

    • Principal Investigator On

    Investigator On

    Full Name

  • S.Vamsee Raju